Last reviewed · How we verify

Fibrin adhesive — Competitive Intelligence Brief

Fibrin adhesive (Fibrin adhesive) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hemostatic agent / Tissue adhesive. Area: Surgery / Hemostasis.

phase 3 Hemostatic agent / Tissue adhesive Fibrinogen / Thrombin pathway Surgery / Hemostasis Small molecule Live · refreshed every 30 min

Target snapshot

Fibrin adhesive (Fibrin adhesive) — Tigenix S.A.U.. Fibrin adhesive acts as a biological glue that promotes hemostasis and tissue adhesion by mimicking the final stages of the coagulation cascade to form a stable fibrin clot.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fibrin adhesive TARGET Fibrin adhesive Tigenix S.A.U. phase 3 Hemostatic agent / Tissue adhesive Fibrinogen / Thrombin pathway

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hemostatic agent / Tissue adhesive class)

  1. Tigenix S.A.U. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fibrin adhesive — Competitive Intelligence Brief. https://druglandscape.com/ci/fibrin-adhesive. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: